Co-Diagnostics CODX Income Statement (2016-2026)

NASDAQ CODX
$1.08 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT
Reported Financials

Co-Diagnostics Quarterly Income Statement

Periods 40 quarters
Latest Jun 2026

Co-Diagnostics reported revenue of $0.17M and net income of -$6.28M for the quarter ended Jun 2026, up 230.4% year over year. This income statement covers 40 quarters of results from Jun 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
28.89M28.89M33.82M33.99M33.78M30.92M30.87M30.63M30.79M30.66M31.26M31.28M31.91M31.93M33.05M33.71M38.52M37.89M1.33M4.31M
Revenue & cost
Revenue
27.36M30.10M20.40M22.70M5.02M5.09M1.40M0.60M0.20M2.46M3.56M0.47M2.66M0.64M0.15M0.05M0.16M0.15M0.26M0.17M
Gross Profit
24.85M26.79M17.91M19.42M4.11M4.33M0.89M0.10M-0.26M2.20M0.59M0.23M2.44M0.34M-0.11M0.03M0.13M0.12M0.12M0.12M
Operating items
Research & DevelopmentR&D
4.67M5.89M2.18M3.77M3.89M5.04M4.74M5.01M5.98M5.79M6.18M5.68M5.61M4.88M4.81M4.87M4.69M4.48M5.10M4.15M
Selling, General & AdministrativeSG&A
2.47M2.92M3.23M2.92M2.47M3.62M5.25M3.01M3.71M3.15M4.40M2.92M3.13M4.29M5.82M2.77M2.60M1.82M1.87M1.50M
Other Operating ExpensesOther Opex
5.93M4.35M2.20M2.90M1.90M2.20M17.02M2.02M2.04M2.20M1.83M1.89M1.38M1.41M1.18M0.94M0.90M0.84M19.70M0.67M
Operating ExpensesOpex
13.06M13.16M7.61M9.59M8.25M10.86M27.01M10.05M11.73M11.14M12.41M10.49M10.12M10.58M11.80M8.58M8.19M7.13M26.66M6.32M
Operating IncomeOp. Inc
11.79M13.63M10.31M9.82M-4.15M-6.54M-26.12M-9.95M-11.99M-8.94M-11.83M-10.26M-7.68M-10.23M-11.91M-8.55M-8.06M-7.01M-26.54M-6.20M
EBIT
11.79M13.63M10.31M9.82M-4.15M-6.54M-26.12M-9.95M-11.99M-8.94M-11.83M-10.26M-7.68M-10.23M-11.91M-8.55M-8.06M-7.01M-26.54M-6.20M
Non-operating items
Non Operating Interest Expenses
Non Operating Investment Income
0.13M-0.06M0.36M-0.09M-0.05M0.00M0.42M0.41M0.43M0.99M0.23M0.07M0.29M0.28M0.30M0.34M0.04M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.01M0.01M0.06M0.30M0.33M0.20M0.19M0.32M0.44M0.36M0.34M0.26M0.12M0.01M0.01M0.01M0.25M0.02M
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
0.14M-0.05M-0.06M3.28M0.72M3.06M1.08M1.94M0.84M0.84M0.98M0.97M0.10M0.56M0.87M1.03M0.34M-0.04M0.32M-0.06M
Net income details
EBT
11.93M13.58M10.24M13.10M-3.43M-3.48M-25.04M-8.02M-11.16M-8.10M-10.84M-9.29M-7.58M-9.67M-11.04M-7.52M-7.72M-7.05M-26.22M-6.26M
Tax ProvisionsTaxes
2.15M2.10M2.75M1.39M-0.74M-2.11M-3.14M-2.26M-2.24M-2.11M3.83M0.02M0.02M0.02M-0.01M0.01M0.01M-1.17M-0.47M0.02M
Profit After TaxPAT
9.79M11.48M7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-6.28M
Income from Continuing OperationsIncome (Continuing)
9.79M11.48M7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-6.28M
Consolidated Net IncomeConsol Net Inc.
9.79M11.48M7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-6.28M
Income towards Parent CompanyParent Net Inc
9.79M11.48M7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-6.28M
Net Income towards Common StockholdersNet Income
9.79M11.48M7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-6.28M
Additional items
EPS (Basic)
0.340.400.260.35-0.08-0.04-0.70-0.20-0.31-0.20-0.50-0.31-0.25-0.32-0.36-0.24-0.23-0.16-19.35-1.46
EPS (Diluted)
0.330.380.250.34-0.08-0.04-0.70-0.20-0.31-0.20-0.50-0.31-0.25-0.32-0.36-0.24-0.23-0.16-19.35-1.46
Shares Outstanding
28.79M28.94M28.87M33.94M32.47M31.32M31.48M29.48M29.09M29.36M29.35M29.84M30.12M30.49M30.34M32.05M33.11M37.89M1.33M4.31M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
29.74M29.95M29.90M34.71M32.47M31.32M31.48M29.48M29.09M29.36M29.35M29.84M30.12M30.49M30.34M32.05M33.11M37.89M1.33M4.31M
EBITDA
11.86M13.72M10.41M10.07M-3.72M-6.22M-25.82M-9.63M-11.69M-8.64M-11.51M-9.93M-7.34M-9.88M-11.55M-8.27M-7.77M-6.75M-26.27M-6.00M
Interest ExpensesInt Expense
Tax Rate
17.9815.4726.8010.58

Co-Diagnostics Income Statement API

Pull Co-Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CODX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY